References
- Zhou L, Yong X, Zhou J, Xu J, Wang C. Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingiva. BioMed Res Int. 2020;2020:9791208. DOI: 10.1155/2020/9791208.
- Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, et al. NUT carcinoma of the salivary glands. Clinicopathologic and molecular analysis of three cases and a survey of NUT expression in salivary gland carcinomas. American J Surg Pathol. 2018;42(7):877-84. DOI: 10.1097/PAS.0000000000001046.
- Chau NG, Ma C, Danga K, Al-Sayegh H, Nardi V, Barrette R, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2019;4(2):pkz094. DOI: 10.1093/jncics/pkz094.
- Mills AF, Lanfranchi M, Wein RO, Mukand-Cerro I, Pilichowska M, Cowan J, et al. NUT midline carcinoma: a case report with a novel translocation and review of the literature. Head Neck Pathol. 2014;8(2):182-6. DOI: 10.1007/ s12105-013-0479-3.
- Liu S, Ferzli G. NUT carcinoma: a rare and devastating neoplasm. BMJ Case Reports. 2018;2018:bcr-2018. DOI: 10.1136/bcr-2018-226526.
- Hsieh MS, French CA, Liang CW, Hsiao CH. NUT midline carcinoma: case report and review of the literature. Int J SurgPathol. 2011;19(6):808-12. DOI: 10.1177/1066896909353600.
- Shiota H, Barral S, Buchou T, Tan M, Coute Y, Charbonnier G, et al. NUT directs p300-dependent, genome-wide H4 hyperacetylation in male germ cells. Cell Rep. 2018;24(13):3477-87.e6. DOI: 10.1016/j.celrep.2018.08.069.
- Napolitano M, Venturelli M, Molinaro E, Toss A. NUT midline carcinoma of the head and neck: current perspectives. Onco Targets Ther. 2019;12:3235-44. DOI: 10.2147/OTT.S173056.
- French CA, Rahman S, Walsh EM, Kuhnle S, Grayson AR, Lemieux ME, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4(8):928-41. DOI: 10.1158/2159-8209.CD-14-0014.
- French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27(15):2237-42. DOI: 10.1038/sj.onc.1210852.
- Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114(21):E4184-92. DOI: 10.1073/pnas.1702086114.
- Lee JK, Louzada S, An Y, Kim SY, Kim S, Youk J, et al. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Ann Oncol. 2017;28(4):890-7. DOI: 10.1093/annonc/mdw686.
- Wang S, Li J, Tong W, Li H, Feng Q, Teng B. Advances in the pathogenesis and treatment of nut carcinoma: a narrative review. Transl Cancer Res. 2020;9(10):6505-15. DOI: 10.21037/tcr-20-1884.
- Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, et al. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2014;33(13):1736-42. DOI: 10.1038/onc.2013.126.
- Giridhar P, Mallick S, Kashyap L, Rath GK. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol. 2018;275(3):815-21. DOI: 10.1107/s00405-018-4882-y.
- do Amparo Veloso Magalhães M, Carvalho Batista NJ, and Grivicich I. Nut mid-line carcinoma: a case report. International Journal of Development Research. 2016;06(10):9719-21.
- Wei X, Teng X, Zhang Y, Cheng M, Chen G. Case report: NUT carcinoma in an elderly woman with unique morphology and immunophenotype highlights a diagnostic pitfall. Transl Cancer Res. 2022;11(6):1850-60. DOI: 10.21037/tcr-22-364.
- Kakkar A, Antony VM, Irugu DVK, Adhikari N, Jain D. NUT midline carcinoma: a series of five cases, including one with unusual clinical course. Head Neck Pathol. 2018;12(2):230-6. DOI: 10.1007/s12105-017-0858-2.
- Minato H, Kobayashi E, Nakada S, Kurose N, Tanaka M, Tanaka Y, et al. Sinonasal NUT carcinoma: clinicopathological and cytogenetic analysis with autopsy findings. Hum Pathol. 2018;71:157-65. DOI: 10.1016/j.humpath.2017.10.011.
- Lee T, Cho J, Baek CH, Son YI, Jeong HS, Chung MK, et al. Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review. Head Neck. 2020;42(5):924-38. DOI: 10.1002/hed.26067.
- Vakani PN, Maheshwari J, Maheshwari M, Shah B. Sinonasal NUT midline carcinoma: A new histological entity. Indian J Pathol Microbiol. 2020;63(1):103-5. DOI: 10.4103/IJPM.IJPM_373_19.
- Saik WN, Da Forno P, Thway K, Khurram SA. NUT carcinoma arising from the parotid gland: a case report and review of the literature. Head Neck Pathol. 2021;15(3):1064-8. DOI: 10.1007/s12105-020-01254-9.
- Patil VM, Toshniwal A, Noronha V, Joshi A, Menon N, Banavali S, et al. NUT midline carcinoma. Clin Oncol (R Coll Radiol). 2019;31(10):732. DOI: 10.1016/j.clon.2019.06.012.
- Rajan A. A hard nut to crack: Case report on nut midline carcinoma-a rare sino-nasal malignancy. JMSCR. 2020;8(5):342-5. DOI: 10.18535/jmscr/v8i5.63.
- Aryakrishna SL, Kumar R, Rafi M, Mathews A. Nut midline carcinoma-nasal cavity-A case report. JMSCR. 2020;8(6):437-40. DOI: 10.18535/jmscr/v8i6.83.
- Patel SA, Singer B, Shen C, Zanation AM, Yarbrough WG, Weiss J. A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nabpaclitaxel. Clin Case Rep. 2021;9:e04616. DOI: 10.1002/ccr3.4616.
- Elkhatib SK, Neilsen BK, Sleightholm RL, Baine MJ, Zhen W. A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature. J Med Case Reports. 2019;13(1):57. DOI: 10.1186/s13256-019-2015-x.
- Albrecht T, Harms A, Roessler S, Goeppert B. NUT carcinoma in a nutshell: A diagnosis to be considered more frequently. Pathol Res Pract. 2019;215(6):152347. DOI: 10.1016/j.prp.2019.01.043.
- Klijanienko J, Le Tourneau C, Rodriguez J, Caly M, theocharis S. Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature. Diagn Cytopathol. 2016;44(9):753-6. DOI: 10.1002/dc.23506.
- Arimizu K, Hirano G, Makiyama C, Matsuo M, Sasaguri T, Makiyama A. NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report. BMC Cancer. 2018;18:1134. DOI: 10.1186/s12885-018-5087-x.
- Seim NB, Philips RHW, Schoenfield L, Teknos TN, Rocco JW, Agrawal A, et al. NUT midline carcinoma of the sublingual gland: Clinical presentation and review. Head Neck Pathol. 2017;11(4):460-8. DOI: 10.1007/s12105-017-0809-y.
- Oliveira LJC, Gongora ABL, Latancia MT, Barbosa FG, Gregorio JVAM, Testagrossa LA, et al. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report. J Med Case Rep. 2019;13:279. DOI: 10.1186/ s13256-019-2213-6.
- D’Souza JN, Notz G, Bogdasarian RN, Cognetti DM, Curry JM, Rosen MR, et al. Orbital involvement by NUT midline carcinoma. Ophthalmic Plast Reconstr Surg. 2015;31(6):e147-50. DOI: 10.1097/IOP.0000000000000179.
- Ding T, Wang Y, Zhao T, Xu Z, Gao W, Cui Z, et al. NUT midline carcinoma in the right orbit: a case report. Cancer Biol Ther. 2019;20(8):1091-6. DOI: 10.1080/15384047.2019.1598761.
- Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer. 2015;62(4):715-7. DOI: 10.1002/pbc.25350.
- Storck S, Kennedy AL, Marcus KJ, Teot L, Vaughn J, Gnekow AK, et al. Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol. 2017;34(4):231-7. DOI: 10.1080/08880018.2017.1363839.
- Andreasen S, French CA, Josiassen M, Hahn CH, Kiss K. NUT carcinoma of the sublingual gland. Head Neck Pathol. 2016;10(3):362-6. DOI: 10.1007/s12105-015-0672-7.
- Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA. Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer. 2007;49(7):1015-7. DOI: 10.1102/pbc.20755.